Amirhossein Sahebkar: Difference between revisions
Bendegúz Ács (talk | contribs) AfD: Nominated for deletion; see Wikipedia:Articles for deletion/Amirhossein Sahebkar |
The removed section pertains to vandalism and seems to be aimed for vilification. Tags: Manual revert section blanking |
||
(14 intermediate revisions by 11 users not shown) | |||
Line 1: | Line 1: | ||
<!-- Please do not remove or change this AfD message until the discussion has been closed. --> |
|||
{{Article for deletion/dated|page=Amirhossein Sahebkar|timestamp=20240211191708|year=2024|month=February|day=11|substed=yes}} |
|||
<!-- Once discussion is closed, please place on talk page: {{Old AfD multi|page=Amirhossein Sahebkar|date=11 February 2024|result='''keep'''}} --> |
|||
<!-- End of AfD message, feel free to edit beyond this point --> |
|||
{{BLP sources|date=April 2022}} |
|||
{{Infobox scientist |
{{Infobox scientist |
||
| honorific_prefix = |
| honorific_prefix = |
||
| name =Amirhossein Sahebkar |
| name = Amirhossein Sahebkar |
||
| honorific_suffix = |
| honorific_suffix = |
||
| native_name = امیرحسین صاحبکار |
| native_name = امیرحسین صاحبکار |
||
Line 25: | Line 19: | ||
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}--> |
| resting_place_coordinates = <!--{{coord|LAT|LONG|type:landmark|display=inline,title}}--> |
||
| other_names = |
| other_names = |
||
| siglum = |
| siglum = |
||
| pronounce = |
| pronounce = |
||
| citizenship = <!-- use only when necessary per [[WP:INFONAT]] --> |
| citizenship = <!-- use only when necessary per [[WP:INFONAT]] --> |
||
| nationality = <!-- use only when necessary per [[WP:INFONAT]] --> |
| nationality = <!-- use only when necessary per [[WP:INFONAT]] --> |
||
| fields = |
| fields = Medical biotechnology, cardiovascular disease |
||
| workplaces = |
| workplaces = Mashhad University of Medical Sciences |
||
| patrons = |
| patrons = |
||
| education = [[Mashhad University of Medical Sciences]] (PhD) |
| education = [[Mashhad University of Medical Sciences]] (PharmD, PhD) |
||
| alma_mater = |
| alma_mater = |
||
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )--> |
| thesis_title = <!--(or | thesis1_title = and | thesis2_title = )--> |
||
Line 50: | Line 44: | ||
| partner = <!--(or | partners = )--> |
| partner = <!--(or | partners = )--> |
||
| children = |
| children = |
||
| parents = |
| parents = |
||
| father = |
| father = |
||
| mother = |
| mother = |
||
| relatives = |
| relatives = |
||
| signature = <!--(filename only)--> |
| signature = <!--(filename only)--> |
||
| signature_alt = |
| signature_alt = |
||
Line 59: | Line 53: | ||
| footnotes = |
| footnotes = |
||
}} |
}} |
||
'''Amirhossein Sahebkar''' is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the [[Mashhad University of Medical Sciences]]. |
|||
'''Amirhossein Sahebkar''' is an Iranian biotechnologist and Associate Professor of Pharmaceutical Biotechnology at [[Mashhad University of Medical Sciences]] and Honorary Research Fellow at [[UWA Medical School]].<ref>{{cite web |title=Amirhossein Sahebkar |url=https://research-repository.uwa.edu.au/en/persons/amirhossein-sahebkar |website=the UWA Profiles and Research Repository |language=en}}</ref> |
|||
He is one of the top highly-cited researchers (h>100) according to [[webometrics]].<ref>{{cite web |title=Highly Cited Researchers (h>100) according to their Google Scholar Citations public profiles {{!}} Ranking Web of Universities: Webometrics ranks 30000 institutions |url=https://www.webometrics.info/en/hlargerthan100 |website=www.webometrics.info}}</ref> |
|||
== Life == |
|||
Sahebkar completed a Pharm.D. in 2008 from [[Mashhad University of Medical Sciences]].<ref name=":0">{{Cite web |last=Sahebkar |first=Amirhossein |title=Resume |url=https://usern.tums.ac.ir/User/CV/A_sahebkar |access-date=2024-02-17 |website=[[USERN]]}}</ref> His dissertation was titled, ''An investigation of serum antibody titres to heat shock protein 27 (anti- Hsp27) as a biomarker for the detection of acute coronary syndrome''.<ref name=":0" /> Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. His dissertation was titled, ''Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction''.<ref name=":0" /> He completed a postdoctoral fellowship in cardiometabolic diseases at the [[University of Western Australia]].<ref name=":1">{{Cite web |date=2018-02-02 |title=دانشمند برگزیده دهه اخیر کشور در علومپزشکی کیست؟ |url=https://www.khabaronline.ir/news/751424/%D8%AF%D8%A7%D9%86%D8%B4%D9%85%D9%86%D8%AF-%D8%A8%D8%B1%DA%AF%D8%B2%DB%8C%D8%AF%D9%87-%D8%AF%D9%87%D9%87-%D8%A7%D8%AE%DB%8C%D8%B1-%DA%A9%D8%B4%D9%88%D8%B1-%D8%AF%D8%B1-%D8%B9%D9%84%D9%88%D9%85-%D9%BE%D8%B2%D8%B4%DA%A9%DB%8C-%DA%A9%DB%8C%D8%B3%D8%AA |access-date=2024-02-17 |website=www.khabaronline.ir |language=fa}}</ref> |
|||
Sahebkar is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.<ref name=":2">{{Cite web |date=2018-02-02 |title=انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی |url=https://www.isna.ir/news/96111307311/%D8%A7%D9%86%D8%AA%D8%AE%D8%A7%D8%A8-%D8%AF%DA%A9%D8%AA%D8%B1-%D8%B5%D8%A7%D8%AD%D8%A8%DA%A9%D8%A7%D8%B1-%D8%A8%D8%B9%D9%86%D9%88%D8%A7%D9%86-%D8%AF%D8%A7%D9%86%D8%B4%D9%85%D9%86%D8%AF-%D8%A8%D8%B1%DA%AF%D8%B2%DB%8C%D8%AF%D9%87-%D8%AF%D9%87%D9%87-%D8%A7%D8%AE%DB%8C%D8%B1-%D8%AF%D8%B1-%D8%AD%D9%88%D8%B2%D9%87-%D8%B9%D9%84%D9%88%D9%85 |access-date=2024-02-17 |website=ایسنا |language=fa}}</ref> His research focuses on cardiovascular disease, [[atherosclerosis]], and [[blood lipids]].<ref name=":2" /> He is a member of the [[Iran's National Elites Foundation]].<ref name=":0" /> In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the [[Iranian Academy of Medical Sciences]].<ref name=":2" /><ref name=":1" /> |
|||
== References == |
== References == |
Latest revision as of 17:04, 12 September 2024
Amirhossein Sahebkar | |
---|---|
امیرحسین صاحبکار | |
Education | Mashhad University of Medical Sciences (PharmD, PhD) |
Scientific career | |
Fields | Medical biotechnology, cardiovascular disease |
Institutions | Mashhad University of Medical Sciences |
Amirhossein Sahebkar is an Iranian biotechnologist specializing in cardiovascular diseases. He is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.
Life
[edit]Sahebkar completed a Pharm.D. in 2008 from Mashhad University of Medical Sciences.[1] His dissertation was titled, An investigation of serum antibody titres to heat shock protein 27 (anti- Hsp27) as a biomarker for the detection of acute coronary syndrome.[1] Sahebkar earned a Ph.D. in pharmaceutical biotechnology from the Mashhad University of Medical Sciences. His dissertation was titled, Preparation and evaluation of nanoliposomes conjugated with apolipoprotein B-100 antibodies as a therapeutic option for serum LDL reduction.[1] He completed a postdoctoral fellowship in cardiometabolic diseases at the University of Western Australia.[2]
Sahebkar is a faculty member in the department of medical biotechnology at the Mashhad University of Medical Sciences.[3] His research focuses on cardiovascular disease, atherosclerosis, and blood lipids.[3] He is a member of the Iran's National Elites Foundation.[1] In 2016, he was presented the Professor Dr. Fereydoun Azizi award by the Iranian Academy of Medical Sciences.[3][2]
References
[edit]- ^ a b c d Sahebkar, Amirhossein. "Resume". USERN. Retrieved 2024-02-17.
- ^ a b "دانشمند برگزیده دهه اخیر کشور در علومپزشکی کیست؟". www.khabaronline.ir (in Persian). 2018-02-02. Retrieved 2024-02-17.
- ^ a b c "انتخاب دکتر صاحبکار بعنوان دانشمند برگزیده دهه اخیر در حوزه علوم پزشکی". ایسنا (in Persian). 2018-02-02. Retrieved 2024-02-17.